Sign In

Login

Password

Forgot Password ? Sign Up

Ryzykowny stan psychiczny (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ryzykowny stan psychiczny" in Polish language version.

refsWebsite
Global rank Polish rank
34nih.gov
4th place
7th place
30doi.org
2nd place
6th place

doi.org (Global: 2nd place; Polish: 6th place)

doi.org

  • B. Nelson, A. Thompson, A.R. Yung. Basic self-disturbance predicts psychosis onset in the ultra high risk for psychosis „prodromal” population. „Schizophrenia Bulletin”. 38 (6), s. 1277–1287, 2012. DOI: 10.1093/schbul/sbs007. PMID: 22349924. 
  • A.R. Yung, B. Nelson, C. Stanford, M.B. Simmons i inni. Validation of „prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. „Schizophrenia Research”. 105 (1–3), s. 10–17, 2008. DOI: 10.1016/j.schres.2008.07.012. PMID: 18765167. 
  • A.R. Yung, L.J. Phillips, H.P. Yuen, P.D. McGorry. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. „Schizophrenia Research”. 67 (2–3), s. 131–142, 2004. DOI: 10.1016/S0920-9964(03)00192-0. PMID: 14984872. 
  • P. Fusar-Poli, I. Bonoldi, A.R. Yung, S. Borgwardt i inni. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. „Archives of General Psychiatry”. 69 (3), s. 220–229, 2012. DOI: 10.1001/archgenpsychiatry.2011.1472. PMID: 22393215. 
  • A.R. Yung, H.P. Yuen, P.D. McGorry, L.J. Phillips i inni. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. „Australian and New Zealand Journal of Psychiatry”. 39 (11–12), s. 964–971, 2005. DOI: 10.1111/j.1440-1614.2005.01714.x. PMID: 16343296. 
  • K.A. Olsen, B. Rosenbaum. Prospective investigations of the prodromal state of schizophrenia: review of studies. „Acta Psychiatr Scand”. 113 (4), s. 247–272, 2006. DOI: 10.1111/j.1600-0447.2005.00697.x. PMID: 16638070. 
  • S.J. Borgwardt, A. Riecher-Rössler, P. Dazzan, X. Chitnis i inni. Regional gray matter volume abnormalities in the at risk mental state. „Biological Psychiatry”. 61 (10), s. 1148–1156, 2007. DOI: 10.1016/j.biopsych.2006.08.009. PMID: 17098213. 
  • SJ. Borgwardt, P.K. McGuire, J. Aston, G. Berger i inni. Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. „British Journal of Psychiatry. Supplement”. 51, s. s69–75, 2007. DOI: 10.1192/bjp.191.51.s69. PMID: 18055941. 
  • S. Benetti, A. Mechelli, M. Picchioni, M. Broome i inni. Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. „Brain”. 132 (Pt 9), s. 2426–2436, 2009. DOI: 10.1093/brain/awp098. PMID: 19420091. 
  • N. Koutsouleris, K. Patschurek-Kliche, J. Scheuerecker, P. Decker i inni. Neuroanatomical correlates of executive dysfunction in the at-risk mental state for psychosis. „Schizophrenia Research”. 123 (2–3), s. 160–174, 2010. DOI: 10.1016/j.schres.2010.08.026. PMID: 20826078. 
  • W.J. Brewer, S.M. Francey, S.J. Wood, H.J. Jackson i inni. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. „American Journal of Psychiatry”. 162 (1), s. 71–78, 2005. DOI: 10.1176/appi.ajp.162.1.71. PMID: 15625204. 
  • M.O. Pflueger, U. Gschwandtner, R.D. Stieglitz, A. Riecher-Rössler. Neuropsychological deficits in individuals with an at risk mental state for psychosis - working memory as a potential trait marker. „Schizophrenia Research”. 97 (1–3), s. 14–24, 2007. DOI: 10.1016/j.schres.2007.09.003. PMID: 17936587. 
  • S.W. Woods, B.C. Walsh, J.R. Saksa, T.H. McGlashan. The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome. „Schizophrenia Research”. 123 (2–3), s. 199–207, 2010. DOI: 10.1016/j.schres.2010.08.012. PMID: 20832249. 
  • A.R. Yung, B. Nelson, A.D. Thompson, S.J. Wood. Should a „Risk Syndrome for Psychosis” be included in the DSMV?. „Schizophrenia Research”. 120 (1–3), s. 7–15, 2010. DOI: 10.1016/j.schres.2010.03.017. PMID: 20382506. 
  • W.T. Carpenter, J. van Os. Should attenuated psychosis syndrome be a DSM-5 diagnosis?. „American Journal of Psychiatry”. 168 (5), s. 460–463, 2011. DOI: 10.1176/appi.ajp.2011.10121816. PMID: 21536700. 
  • N. Tandon, J. Shah, M.S. Keshavan, R. Tandon. Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention. „Neuropsychiatry (London)”. 2 (4), s. 345–353, 2012. DOI: 10.2217/npy.12.36. PMID: 23125875. 
  • P. Fusar-Poli, A.R. Yung. Should attenuated psychosis syndrome be included in DSM-5?. „Lancet”. 379 (9816), s. 591–592, 2012. DOI: 10.1016/S0140-6736(11)61507-9. PMID: 22340290. 
  • A.R. Yung, S.W. Woods, S. Ruhrmann, J. Addington i inni. Whither the attenuated psychosis syndrome?. „Schizophrenia Bulletin”. 38 (6), s. 1130–1134, 2012. DOI: 10.1093/schbul/sbs108. PMID: 23144056. 
  • A.E. Simon, A. Riecher-Rössler, U.E. Lang, S. Borgwardt. The attenuated psychosis syndrome in DSM-5. „Schizophrenia Research”. 151 (1–3), s. 295, 2013. DOI: 10.1016/j.schres.2013.09.019. PMID: 24094680. 
  • W.T. Carpenter. Attenuated psychosis syndrome: need for debate on a new disorder. „Psychopathology”. 47 (5), s. 287–291, 2014. DOI: 10.1159/000365221. PMID: 25060627. 
  • B. Nelson. Attenuated psychosis syndrome: don't jump the gun.. „Psychopathology”. 47 (5), s. 292–296, 2014. DOI: 10.1159/000365291. PMID: 25011580. 
  • P. Fusar-Poli, W.T. Carpenter, S.W. Woods, T.H. McGlashan. Attenuated psychosis syndrome: ready for DSM-5.1?. „Annual Review of Clinical Psychology”. 10, s. 155-192, 2014. DOI: 10.1146/annurev-clinpsy-032813-153645. PMID: 24471375. 
  • W.T. Carpenter, D. Regier, R. Tandon. Misunderstandings about attenuated psychosis syndrome in the DSM-5. „Schizophrenia Research”. 152 (1), s. 303, 2014. DOI: 10.1016/j.schres.2013.11.020. PMID: 24331869. 
  • W.T. Carpenter, J. Schiffman. Diagnostic Concepts in the Context of Clinical High Risk/Attenuated Psychosis Syndrome. „Schizophrenia Bulletin”. 41 (5), s. 1001–1002, 2015. DOI: 10.1093/schbul/sbv095. PMID: 26163478. 
  • International clinical practice guidelines for early psychosis. „British Journal of Psychiatry. Supplement”. 48, s. s120–124, 2005. DOI: 10.1192/bjp.187.48.s120. PMID: 16055801. 
  • S.J. Schmidt, F. Schultze-Lutter, B.G. Schimmelmann, N.P. Maric i inni. EPA guidance on the early intervention in clinical high risk states of psychoses. „European Psychiatry”. 30 (3), s. 388–404, 2015. DOI: 10.1016/j.eurpsy.2015.01.013. PMID: 25749390. 
  • A. Preti, M. Cella. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. „Schizophrenia Research”. 123 (1), s. 30–36, 2010. DOI: 10.1016/j.schres.2010.07.026. PMID: 20727717. 
  • M. van der Gaag, F. Smit, A. Bechdolf, P. French i inni. Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. „Schizophrenia Research”. 149 (1-3), s. 56–62, 2013. DOI: 10.1016/j.schres.2013.07.004. PMID: 23870806. 
  • M.R. Stafford, H. Jackson, E. Mayo-Wilson, A.P. Morrison i inni. Early interventions to prevent psychosis: systematic review and meta-analysis. „BMJ”. 346, s. f185, 2013. DOI: 10.1136/bmj.f185. PMID: 23335473. 

dx.doi.org

  • Inti Qurashi i inni, A randomised, double-blind, placebocontrolled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol, „Trials”, 18:524, 2017, DOI: 10.1186/s13063-017-2275-y.

nih.gov (Global: 4th place; Polish: 7th place)

ncbi.nlm.nih.gov

  • A.R. Yung, L.J. Phillips, H.P. Yuen, S.M. Francey i inni. Psychosis prediction: 12-month follow up of a high-risk („prodromal”) group. „Schizophrenia Research”. 60 (1), s. 21–32, 2003. PMID: 12505135. 
  • B. Nelson, A. Thompson, A.R. Yung. Basic self-disturbance predicts psychosis onset in the ultra high risk for psychosis „prodromal” population. „Schizophrenia Bulletin”. 38 (6), s. 1277–1287, 2012. DOI: 10.1093/schbul/sbs007. PMID: 22349924. 
  • A.R. Yung, B. Nelson, C. Stanford, M.B. Simmons i inni. Validation of „prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. „Schizophrenia Research”. 105 (1–3), s. 10–17, 2008. DOI: 10.1016/j.schres.2008.07.012. PMID: 18765167. 
  • A.R. Yung, L.J. Phillips, H.P. Yuen, P.D. McGorry. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. „Schizophrenia Research”. 67 (2–3), s. 131–142, 2004. DOI: 10.1016/S0920-9964(03)00192-0. PMID: 14984872. 
  • Z. Zuschlag, A. Kennedy, J. Korte, L. Franko-Tobin i inni. DSM-5-defined attenuated psychosis syndrome and conversion to full-scale schizophrenia spectrum disorders: An institution-wide retrospective review. „Annals of Clinical Psychiatry”. 28 (3), s. e1-e10, 2016. PMID: 27490838. 
  • P. Fusar-Poli, I. Bonoldi, A.R. Yung, S. Borgwardt i inni. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. „Archives of General Psychiatry”. 69 (3), s. 220–229, 2012. DOI: 10.1001/archgenpsychiatry.2011.1472. PMID: 22393215. 
  • A.R. Yung, H.P. Yuen, P.D. McGorry, L.J. Phillips i inni. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. „Australian and New Zealand Journal of Psychiatry”. 39 (11–12), s. 964–971, 2005. DOI: 10.1111/j.1440-1614.2005.01714.x. PMID: 16343296. 
  • J. Jaracz, M. Grzechowiak, L. Raczkowiak, K. Rataj i inni. Polska wersja Kompleksowej Oceny Zagrażających Stanów Psychicznych (CAARMS) – opis metody. „Psychiatria Polska”. 46 (1), s. 95–107, 2012. PMID: 23214153. 
  • T.J. Miller, T.H. McGlashan, J.L. Rosen, K. Cadenhead i inni. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. „Schizophrenia Bulletin”. 29 (4), s. 703–715, 2003. PMID: 14989408. 
  • K.A. Olsen, B. Rosenbaum. Prospective investigations of the prodromal state of schizophrenia: review of studies. „Acta Psychiatr Scand”. 113 (4), s. 247–272, 2006. DOI: 10.1111/j.1600-0447.2005.00697.x. PMID: 16638070. 
  • S.J. Borgwardt, A. Riecher-Rössler, P. Dazzan, X. Chitnis i inni. Regional gray matter volume abnormalities in the at risk mental state. „Biological Psychiatry”. 61 (10), s. 1148–1156, 2007. DOI: 10.1016/j.biopsych.2006.08.009. PMID: 17098213. 
  • SJ. Borgwardt, P.K. McGuire, J. Aston, G. Berger i inni. Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. „British Journal of Psychiatry. Supplement”. 51, s. s69–75, 2007. DOI: 10.1192/bjp.191.51.s69. PMID: 18055941. 
  • S. Benetti, A. Mechelli, M. Picchioni, M. Broome i inni. Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. „Brain”. 132 (Pt 9), s. 2426–2436, 2009. DOI: 10.1093/brain/awp098. PMID: 19420091. 
  • N. Koutsouleris, K. Patschurek-Kliche, J. Scheuerecker, P. Decker i inni. Neuroanatomical correlates of executive dysfunction in the at-risk mental state for psychosis. „Schizophrenia Research”. 123 (2–3), s. 160–174, 2010. DOI: 10.1016/j.schres.2010.08.026. PMID: 20826078. 
  • H. Witthaus, U. Mendes, M. Brüne, S. Ozgürdal i inni. Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia. „Journal of Psychiatry & Neuroscience”. 35 (1), s. 33–40, 2010. PMID: 20040244. 
  • W.J. Brewer, S.M. Francey, S.J. Wood, H.J. Jackson i inni. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. „American Journal of Psychiatry”. 162 (1), s. 71–78, 2005. DOI: 10.1176/appi.ajp.162.1.71. PMID: 15625204. 
  • M.O. Pflueger, U. Gschwandtner, R.D. Stieglitz, A. Riecher-Rössler. Neuropsychological deficits in individuals with an at risk mental state for psychosis - working memory as a potential trait marker. „Schizophrenia Research”. 97 (1–3), s. 14–24, 2007. DOI: 10.1016/j.schres.2007.09.003. PMID: 17936587. 
  • S.W. Woods, B.C. Walsh, J.R. Saksa, T.H. McGlashan. The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome. „Schizophrenia Research”. 123 (2–3), s. 199–207, 2010. DOI: 10.1016/j.schres.2010.08.012. PMID: 20832249. 
  • A.R. Yung, B. Nelson, A.D. Thompson, S.J. Wood. Should a „Risk Syndrome for Psychosis” be included in the DSMV?. „Schizophrenia Research”. 120 (1–3), s. 7–15, 2010. DOI: 10.1016/j.schres.2010.03.017. PMID: 20382506. 
  • W.T. Carpenter, J. van Os. Should attenuated psychosis syndrome be a DSM-5 diagnosis?. „American Journal of Psychiatry”. 168 (5), s. 460–463, 2011. DOI: 10.1176/appi.ajp.2011.10121816. PMID: 21536700. 
  • N. Tandon, J. Shah, M.S. Keshavan, R. Tandon. Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention. „Neuropsychiatry (London)”. 2 (4), s. 345–353, 2012. DOI: 10.2217/npy.12.36. PMID: 23125875. 
  • P. Fusar-Poli, A.R. Yung. Should attenuated psychosis syndrome be included in DSM-5?. „Lancet”. 379 (9816), s. 591–592, 2012. DOI: 10.1016/S0140-6736(11)61507-9. PMID: 22340290. 
  • A.R. Yung, S.W. Woods, S. Ruhrmann, J. Addington i inni. Whither the attenuated psychosis syndrome?. „Schizophrenia Bulletin”. 38 (6), s. 1130–1134, 2012. DOI: 10.1093/schbul/sbs108. PMID: 23144056. 
  • A.E. Simon, A. Riecher-Rössler, U.E. Lang, S. Borgwardt. The attenuated psychosis syndrome in DSM-5. „Schizophrenia Research”. 151 (1–3), s. 295, 2013. DOI: 10.1016/j.schres.2013.09.019. PMID: 24094680. 
  • W.T. Carpenter. Attenuated psychosis syndrome: need for debate on a new disorder. „Psychopathology”. 47 (5), s. 287–291, 2014. DOI: 10.1159/000365221. PMID: 25060627. 
  • B. Nelson. Attenuated psychosis syndrome: don't jump the gun.. „Psychopathology”. 47 (5), s. 292–296, 2014. DOI: 10.1159/000365291. PMID: 25011580. 
  • P. Fusar-Poli, W.T. Carpenter, S.W. Woods, T.H. McGlashan. Attenuated psychosis syndrome: ready for DSM-5.1?. „Annual Review of Clinical Psychology”. 10, s. 155-192, 2014. DOI: 10.1146/annurev-clinpsy-032813-153645. PMID: 24471375. 
  • W.T. Carpenter, D. Regier, R. Tandon. Misunderstandings about attenuated psychosis syndrome in the DSM-5. „Schizophrenia Research”. 152 (1), s. 303, 2014. DOI: 10.1016/j.schres.2013.11.020. PMID: 24331869. 
  • W.T. Carpenter, J. Schiffman. Diagnostic Concepts in the Context of Clinical High Risk/Attenuated Psychosis Syndrome. „Schizophrenia Bulletin”. 41 (5), s. 1001–1002, 2015. DOI: 10.1093/schbul/sbv095. PMID: 26163478. 
  • International clinical practice guidelines for early psychosis. „British Journal of Psychiatry. Supplement”. 48, s. s120–124, 2005. DOI: 10.1192/bjp.187.48.s120. PMID: 16055801. 
  • S.J. Schmidt, F. Schultze-Lutter, B.G. Schimmelmann, N.P. Maric i inni. EPA guidance on the early intervention in clinical high risk states of psychoses. „European Psychiatry”. 30 (3), s. 388–404, 2015. DOI: 10.1016/j.eurpsy.2015.01.013. PMID: 25749390. 
  • A. Preti, M. Cella. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. „Schizophrenia Research”. 123 (1), s. 30–36, 2010. DOI: 10.1016/j.schres.2010.07.026. PMID: 20727717. 
  • M. van der Gaag, F. Smit, A. Bechdolf, P. French i inni. Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. „Schizophrenia Research”. 149 (1-3), s. 56–62, 2013. DOI: 10.1016/j.schres.2013.07.004. PMID: 23870806. 
  • M.R. Stafford, H. Jackson, E. Mayo-Wilson, A.P. Morrison i inni. Early interventions to prevent psychosis: systematic review and meta-analysis. „BMJ”. 346, s. f185, 2013. DOI: 10.1136/bmj.f185. PMID: 23335473.